New Journey Health Hits Day Low at CNY 1.95 Amid Price Pressure

New Journey Health Technology Group Co., Ltd. experienced a notable decline today, with the stock dropping by 5.71% and reaching an intraday low of CNY 1.95. This performance contrasts with the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, New Journey Health has remained flat, while the broader index has seen a more significant decline of 5.81%. In the longer term, the stock has shown a mixed performance, with a slight increase of 3.66% over the past month, but a decline of 8.33% over the past year. The company's year-to-date performance stands at -7.04%, underperforming the index's -5.16%. Financially, New Journey Health is net-debt free, yet it has struggled with growth, as evidenced by a mere 0.17% annual increase in net sales over the last five years. The company has reported negative results for the last four consecutive quarters, with a significant drop in net profit and sales. The return on equity remains low at 1.49%, indicating challenges in profitability. Overall, the stock's performance reflects ongoing difficulties in the competitive pharmaceuticals and biotechnology sector.